Global Bovine Pericardial Tissue Valve Market Growth 2025-2031

The global Bovine Pericardial Tissue Valve market size is predicted to grow from US$ 2654 million in 2025 to US$ 4077 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.

A Bovine Pericardial Tissue Valve is a type of biological heart valve made from the pericardium (the membrane surrounding the heart) of cows. These valves are treated and processed to be biocompatible and are typically used for heart valve replacement surgeries. The bovine tissue provides excellent durability and function as a valve material.

Market Overview:

Bovine pericardial valves are commonly used in patients who require a bioprosthetic valve for conditions like aortic stenosis or mitral valve regurgitation. They are favored for their natural flexibility, reduced risk of clotting, and lower need for long-term anticoagulation compared to mechanical valves.

Market Drivers:

Increased demand for bioprosthetic valves over mechanical valves due to their better long-term outcomes and reduced clotting risks.

Technological improvements in tissue preservation, leading to better valve longevity and patient outcomes.

Favorable clinical outcomes, especially in elderly patients and those at high risk for anticoagulant therapy complications.

Market Opportunities:

Ongoing research into improving the durability and anti-calcification properties of bovine pericardial valves.

Expansion of the market in emerging economies where the prevalence of valvular heart disease is rising, but advanced healthcare options are still growing.

Market Limitations:

Bovine pericardial valves typically have a shorter lifespan compared to mechanical valves, which may necessitate reoperation in younger patients.

Concerns about the long-term durability of bovine tissue and the potential for valve degeneration.

LP Information, Inc. (LPI) ' newest research report, the “Bovine Pericardial Tissue Valve Industry Forecast” looks at past sales and reviews total world Bovine Pericardial Tissue Valve sales in 2024, providing a comprehensive analysis by region and market sector of projected Bovine Pericardial Tissue Valve sales for 2025 through 2031. With Bovine Pericardial Tissue Valve sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bovine Pericardial Tissue Valve industry.

This Insight Report provides a comprehensive analysis of the global Bovine Pericardial Tissue Valve landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bovine Pericardial Tissue Valve portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bovine Pericardial Tissue Valve market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bovine Pericardial Tissue Valve and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bovine Pericardial Tissue Valve.

This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Pericardial Tissue Valve market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Stentless
Stented

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Edwards Lifesciences
St. Jude Medical
Meril Life Sciences
Balance Medical
Boston Scientific
Labor
Abbott
Colibri Heart Valve

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bovine Pericardial Tissue Valve market?

What factors are driving Bovine Pericardial Tissue Valve market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bovine Pericardial Tissue Valve market opportunities vary by end market size?

How does Bovine Pericardial Tissue Valve break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.